	US 12,029,722 B2
	Dosage delivery film
Sergey Y. Chistov, Miami, FL (US)
Assigned to Spartak LLC, Manalapan, NJ (US)
Filed by Spartak LLC, Manalapan, NJ (US)
Filed on Nov. 24, 2020, as Appl. No. 17/103,518.
Application 17/103,518 is a continuation of application No. 16/404,581, filed on May 6, 2019, granted, now 10,857,125.
Application 16/404,581 is a continuation of application No. 16/058,669, filed on Aug. 8, 2018, granted, now 10,307,394, issued on Jun. 4, 2019.
Application 16/058,669 is a continuation of application No. 15/611,581, filed on Jun. 1, 2017, granted, now 10,058,531, issued on Aug. 28, 2018.
Prior Publication US 2021/0077456 A1, Mar. 18, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/70 (2006.01); A61K 31/05 (2006.01); A61K 31/343 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61K 47/06 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01)

CPC A61K 31/353 (2013.01) [A61K 9/006 (2013.01); A61K 9/107 (2013.01); A61K 9/1075 (2013.01); A61K 9/7007 (2013.01); A61K 31/05 (2013.01); A61K 31/343 (2013.01); A61K 31/352 (2013.01); A61K 47/06 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01)]

32 Claims

1. An orally administered drug delivery film, comprising:

a polymer of about 20% to about 50%;

a plasticizer of about 6% to about 9%;

a defoamer of about 0.2% to about 0.5%;

an antioxidant of about 0% to about 3%;

a β-cyclodextrin; and

a cannabinoid;

wherein a first portion of said cannabinoid comprises a cannabinoid-β-cyclodextrin complex,

wherein a second portion of said cannabinoid comprises a micelle,

wherein said micelle having a hydrophobic core of said cannabinoid and a hydrophilic shell of a surfactant; and

water of about 30% to about 60%.